Extraterritoriality agreement – maybe today, maybe tomorrow…

Extraterritoriality agreements for cross-border OTC derivatives have been hotly debated for a while now, but there have been few visible signs of progress in recent months. Last week the Chairman of the US SEC, Elisse Walter, presented her views on the complex area of equivalence and reciprocity. In her speech she referred to the problems that domestic regulators would face if forced to accept the full scope of foreign regulation as equivalent in order to receive reciprocity. She argues that this “all-in approach” limits regulators considerably and advocates, instead, a new approach that would allow regulators to accept certain parts of foreign regulation as equivalent, while fully enforcing other parts of domestic regulation on foreign firms.

This has obvious benefits for the SEC and other regulatory bodies, allowing them to make more precise decisions and quickly agreeing on undisputed rules which are fairly similar around the world. However, it fails to address many of the issues faced by trading firms – for example, foreign privacy laws restricting them from reporting counterparty information to US trade repositories.

So, while regulators might introduce globally consistent rules tomorrow, FCMs and brokers must find solutions today. Without smart workflow and global data management that can handle every domestic idiosyncrasy, it’s hard to see how anyone will avoid the wrath of the regulator.

Leave A Comment

Copyright © 2019 Fidessa Group Holdings Limited. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.